Paper
Document
Download
Flag content
0

411MO Petosemtamab (MCLA-158) monotherapy in previously treated (2L+) recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase II trial

0
TipTip
Save
Document
Download
Flag content